Regular ArticlesEfficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen
Under an Elsevier user license
open archive
Keywords
COX-2 specific inhibitors, NSAIDs, Osteoarthritis, Valdecoxib
Cited by (0)
- f1
Address correspondence to: David P. Recker, Clinical Research and Development, Pharmacia Corporation, 5200 Old Orchard Road, Skokie, IL 60077, U.S.A. Tel: 847 581 5867; Fax: 847 581 4742; E-mail: [email protected]
Copyright © 2002 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.